Page 10«..9101112..2030..»

Growing back the lymph system | News | albanyherald.com – The Albany Herald

§ May 26th, 2020 § Filed under Nano Medicine Comments Off on Growing back the lymph system | News | albanyherald.com – The Albany Herald

ATHENS A team including University of Georgia researchers has for the first time documented the regrowth of surgically removed pathways in the lymphatic system, a network of vessels designed to pump away inflammatory fluids and defend the body against infection.

Published in Nature Biomedical Engineering, the findings lay the foundation for a new class of treatment options for lymph-related disorders, such as chronic wound complications, and could even help prevent the spread of cancer.

Lymphatic dysfunction is connected to a variety of diseases, including both cardiovascular disease and cancer. For example, breast cancer cells break away from the primary tumor and travel through the lymphatic system. If left alone, they can spread throughout the body. Lymphatic vessels which operate in similar ways to the cardiovascular system are sometimes traumatized by cancer treatment or the removal of lymph nodes, which can lead to lymphedema, or the chronic swelling of a leg or arm.

Right now, we dont have a way to rebuild or reconstruct the lymphatic system. We hardly even understand how it works, John Peroni, a professor and large-animal surgeon in UGAs College of Veterinary Medicine, said. This study was one of the first in fundamentally addressing a basic scientific question that has been left unanswered: If lymphatics are injured, can they remodel or heal?

Working with a sheep model, collaborators from Georgia Tech and the Regenerative Bioscience Center at UGAs College of Agricultural and Environmental Sciences removed one of two lymphatic vessels that run parallel to each other in the leg. These are as crucial to lymph flow as the heart is to blood flow, according to the researchers. Under these conditions, they were able to show the beginning of a lymphatic pump cycle and the start of the remodeling and repair stages.

As a result of the remodeling, the team concluded that molecular changes in lymphatic muscle cells enhanced oxidative stress, which typically occurs when the immune system is creating inflammation to fight off bacteria. After a period of six weeks, the team discovered that the remaining lymphatic vessel was working twice as hard to compensate for the oxidative stress.

One would expect that when you remove the main lymph vessel, in the part thats lower than the obstruction, it would swell. To our surprise, it only did so minimally, Peroni said. It turns out theres a considerable amount of collateral lymphatic circulation that we were not expecting. At a microscopic level, theres enough mechanisms by which the body can still recirculate and drain fluids out of the leg, even though the main highway is removed.

The findings follow the same researchers previous work that showed similar results in using the rodent tail, one of the oldest and most widely utilized model systems for lymphatic research.

Perhaps the most important single feature of using a larger model like sheep, versus the historical benchmark of a rodents tail, is the gravitational benefits, Peroni said. Gravity makes it harder for lymph to be transported from the legs and the lower half of the body, and sheep provide a better gravitational model compared to the consistently flat position of a rodents tail. Its almost identical to wound-healing issues in humans.

Peroni worked closely with Brandon Dixon, lead author and associate professor of mechanical and biomedical engineering at Georgia Tech, who heads the Laboratory of Lymphatic Biology and Bioengineering.

What distinguishes this study from others is that it focused on remodeling of the vessel that was not initially damaged during surgery, as it attempts to compensate for the segment that was removed, Dixon said. This is important for understanding secondary lymphedema in breast cancer survivors, since most onset of lymphedema occurs many months after breast cancer surgery, and the remaining intact lymphatic vasculature can no longer keep up with the demands placed on it.

These findings are pre-clinical and further studies are required to confirm testing in humans, but they provide scientific evidence for lymphatic remodeling that up until now has been scarce.

Were excited because there is now an animal model that we can use to put the vessel under this state of prolonged stress that wasnt the result of the initial injury, but a result of the vessels adaptation to the surgery, Dixon said. Its a good model for what happens to a human.

This study was funded by the Regenerative Engineering and Medicine seed grant program. The Regenerative Bioscience Center is a unit of the UGA Office of Research, with support from CAES and its Department of Animal and Dairy Science.

Charlene Betourney is the marketing and development coordinator with the University of Georgia UGA Regenerative Bioscience Center.

Go here to see the original:
Growing back the lymph system | News | albanyherald.com - The Albany Herald

Read the Rest...

A Long Road to Recovery: Lung Rehab Needed After COVID-19 – Medscape

§ May 26th, 2020 § Filed under Nano Medicine Comments Off on A Long Road to Recovery: Lung Rehab Needed After COVID-19 – Medscape

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

If one word describes Eladio ("Lad") Braganza, age 77, it's "tenacious." For 28 days, he clung to life on a ventilator in a Seattle ICU. Now after a 46-day hospitalization for SARS-CoV-2 infection he's making progress in inpatient rehab, determined to regain function.

"We were not sure if he was going to make it through his first night in the hospital, and for a while after that. We were really prepared that he would not survive his ventilator time," his daughter, Maria Braganza, told Medscape Medical News just 5 days after her father had been transferred to inpatient rehab.

In many ways, Braganza's experience is typical of seriously ill COVID-19 patients. Many go from walking and talking to being on a ventilator within 10 hours or less. Braganza was admitted to the hospital on March 21 and was intubated that day. To keep him on the ventilator, he was heavily sedated and unconscious at times. In the ICU, he experienced bouts of low blood pressure, a pattern of shock that occurs in COVID-19 patients and that does not always respond to fluids.

Doctors have quickly learned to treat these patients aggressively. Many patients in the ICU with COVID-19 develop an inflamed, atypical form of acute respiratory distress syndrome (ARDS), in which the lung's compliance, or stiffness, does not match the severity of hypoxia. These patients require high levels of oxygen and high ventilator settings. Many develop pneumothorax, or collapsed lungs, because of the high pressures needed to deliver oxygen and the prolonged time on ventilation.

"The vast majority of COVID patients in the ICU have lung disease that is quite severe, much more severe than I have seen in my 20 years of doing this," said critical care specialist Anna Nolan, MD, an associate professor of medicine at New York University School of Medicine.

After about 2 weeks, some of these patients can come off the ventilator, or they may undergo a tracheostomy, a hole in the neck through which a tube is placed to deliver oxygen. By this time, many have developed ICU-acquired weakness and muscle wasting. Some may be so debilitated that they cannot walk. Even the respiratory muscles that help them breath may have weakened as a result of the ventilator doing the work for them.

These patients "get sick very fast, and it takes a long time for them to heal. What's not really well appreciated is how much rehab and how much recovery time these patients are going to need," said David Chong, MD. He is medical director of the ICU at New YorkPresbyterian Hospital/Columbia University Medical Center, and he has been on the front lines during the COVID-19 surge in New York City.

Regardless of the cause, many people who have a prolonged stint in the ICU face an even longer convalescence. Still-unanswered questions concern whether recovery time will be longer for those with COVID-19 compared to other illnesses and whether some of the damage may be permanent. A number of small studies in Hong Kong and China, as well as studies of SARS patients' recoveries, have promoted speculation about possible long-lasting damage to lungs and other organs from COVID-19.

Yet some of these reports have left out important details about ARDS in COVID-19 patients, who also may be most at risk for long-lasting damage. To clear up some of the confusion, the Pulmonary Fibrosis Foundation said on April 6 that some but not all of COVID-19 patients who develop ARDS may go on to develop lung fibrosis scarring of the lungs which may be permanent.

"Post-ARDS fibrosis typically is not progressive, but nonetheless can be severe and limiting. The recovery period for post-ARDS fibrosis is approximately one year and the residual deficits persist, but generally do not progress," the Foundation noted.

Because the pandemic is only a few months in, it's unclear as yet what the long-term consequences of severe COVID-19 may be. But emerging data are enabling researchers to venture an educated guess about what may happen in the months and years ahead.

The key to understanding the data is knowing that ARDS is a syndrome the end product of a variety of diseases or insults to the lung. Under the microscope, lung damage from ARDS associated with COVID-19 is indistinguishable from lung damage resulting from other causes, such as vaping, sepsis, or shock caused by a motor vehicle accident, said Sanjay Mukhopadhyay, MD, director of pulmonary pathology at Cleveland Clinic.

Mukhopadhyay, who specializes in lung pathology, performed one of the first complete autopsies of a COVID-19 patient in the United States. In most autopsy series published to date, he said, the most common lung finding in patients who have died from COVID-19 is diffuse alveolar damage (DAD), a pattern of lung injury seen in ARDS from many other causes.

In DAD, the walls of the alveoli thinly lined air sacs that facilitate gas exchange in the lung develop a pink, hyaline membrane composed of damaged cells and plasma proteins that leak from capillaries in the wall of the alveolus. This hyaline membrane gets plastered against the wall of the alveolus and interferes with diffusion of oxygen into the body.

"We know what happens in ARDS from other causes. If you follow people who have been on a ventilator long term, some of their respiratory function goes back to normal," Mukhopadhyay said. "But there are other people in whom some degree of respiratory impairment lingers. In these patients, we think the DAD progresses to an organizing stage."

Organizing pneumonia refers to a family of diseases in which fibroblasts (cells involved in wound healing) arrive and form scar tissue that forms hyaline membranes and fibrin balls (tough proteins) that fill up the alveoli, making gas exchange very difficult.

Also called BOOP (bronchiolitis obliterans organizing pneumonia), this condition is sensitive to steroids. Early aggressive steroid treatment can prevent long-term lung damage. Without steroids, damage can become permanent. A variant of this condition is termed acute fibrinous and organizing pneumonia (AFOP), which is also sensitive to steroids. A report from France demonstrates AFOP in some patients who have died from COVID-19.

The trick is identifying who is developing BOOP and who is not, and beyond that, who might be most amenable to treatment. Use of steroids for patients with certain other problems, such as a bacterial infection on top of COVID-19, could be harmful. Chong and colleagues at Columbia University Medical Center are investigating this to determine which COVID-19 patients may benefit from early steroid therapy.

"It's not clear if there is a predominant histologic type or if we are catching people at different phase of their disease, and therefore we're seeing different lung pathology," Chong said.

He thinks that many patients with severe COVID-19 probably will not develop this pattern of lung scarring.

"We're speculating that lung damage from severe COVID-19 is probably going to behave more like lung damage from regular ARDS, which is often reversible. We think the vast majority of these patients probably have DAD that is similar to most patients with ARDS from other etiologies," Chong said.

That would be consistent with information from China. In an April interview with Chinese domestic media, Zhong Nanshan, MD, a pulmonologist at the head of China's COVID-19 task force, stated that he expects that the lungs in most patients with COVID-19 gradually recover. He was responding to a widely publicized small study that found evidence of residual lung abnormalities at hospital discharge in most patients (94%, 66/70) who suffered from COVID-19 pneumonia in Wuhan, China, from January to February 2020.

Experts say that follow-up in this Chinese study and others to date has not nearly been long enough to allow predictions about lasting lung damage in COVID-19.

They also highlight the tough conditions in which researchers are working. Few autopsies have been performed so far autopsies take time, extra precautions must be taken to avoid spread of COVID-19, and many patients and families do not consent to an autopsy. Furthermore, autopsy data from patients who died of COVID-19 may not extrapolate to survivors.

"I would not hang my hat on any of the limited data I have seen on autopsies," said Lina Miyakawa, MD, a critical care and pulmonary medicine specialist at Mount Sinai Hospital in New York City.

"Even though we have answers about how the lungs are damaged at the end stage, this does not elucidate any answers about the earlier lung damage from this disease," she continued. "It would be informative to have pathological data from the early or transitional phase, to see if that may translate into a treatment modality for COVID-19 patients."

The problem is that these patients often experience a large amount of sloughing of airway cells, along with mucous plugging (collections of mucous that can block airflow and collapse alveoli). Bronchoscopy, which is used to view the inside of the lungs and sometimes to retrieve biopsy specimens for microscopic evaluation, is too risky for many COVID-19 patients.

In addition, few CT data exist for severely ill COVID-19 patients, who can be so unstable that to transport them to undergo a CT scan can be dangerous, not to mention the concern regarding infection control.

Even if sufficient data did exist, findings from chest x-rays, CTs, pathology studies, and lung function tests do not always match up. A patient who has lung abnormalities on CT may not necessarily have clinically impaired lung function or abnormal pathologic findings, according to Ali Gholamrezanezhad, MD, an emergency radiologist and assistant professor of clinical radiology with Ketch School of Medicine at the University of Southern California.

Together with colleagues at USC, Gholamrezanezhad has started a long-term study of patients who were hospitalized with COVID-19. The researchers will follow patients for at least 1 year and will use chest x-ray, chest CT, and exercise testing to evaluate lung recovery over time.

"In the acute phase, we have acute inflammation called ground glass opacities, which usually happen bilaterally in COVID-19. That is totally reversible damage that can return to normal with no scarring," Gholamrezanezhad said.

On the basis of data from survivors of other severe pneumonias, such as MERS, SARS-CoV-1 infection, and H1N1 influenza, Gholamrezanezhad thinks that most survivors of COVID-19 will be able to return to work and normal life, although some may show residual lung dysfunction. Age, underlying medical conditions, smoking, length of hospital stay, severity of illness, and quality of treatment may all play a role in how well these people recover.

The lung has a remarkable capacity to recover, he added. Critical illness can destroy type one pneumocytes the cells that line the alveoli in the lung but over time, these cells grow back and reline the lungs. When they do, they can also help repair the lungs.

On top of that, the lung has a large functional reserve, and when one section becomes damaged, the rest of the lung can compensate.

However, for some people, total maximum exercise capacity may be affected, he commented.

Mukhopadhyay said: "My feeling is you will get reversal to normal in some patients and you will get long-term fibrosis from ARDS in some survivors. The question is, how many will have complete resolution and how many will have fibrosis? To know the answer, we will need a lot more data than we have now."

Like many who become seriously ill with COVID-19, Braganza had underlying medical problems. Before becoming ill, he had had a heart attack and stroke. He walked with a walker and had some age-related memory problems.

Five days after transfer to inpatient rehab, Braganza was walking up and down the hallway using a walker. He was still shaking off the effects of being heavily sedated for so long, and he experienced periods of confusion. When he first came off the ventilator, he mixed up days and nights. Sometimes he did not remember being so sick. A former software engineer, Braganza usually had no problem using technology, but he has had to relearn how to use his phone and connect his iPad to Wi-Fi.

"He is still struggling quite a bit with remembering how to do basic things," Maria Braganza said. "He has times of being really depressed because he feels like he's not making progress."

Doctors are taking note and starting to think about what lies ahead for ICU survivors of COVID-19. They worry about the potential for disease recurrence as well as readmission for other problems, such as other infections and hip fractures.

"As COVID-19 survivors begin to recover, there will be a large burden of chronic critical illness. We expect a significant need for rehabilitation in most ICU survivors of COVID-19," said Steve Lubinsky, MD, medical director of respiratory care at New York University Langone Tisch Hospital.

Thinking about her father, Maria Braganza brings an extra dimension to these concerns. She thinks about depression, loneliness, and social isolation among older survivors of COVID-19. These problems existed long before the pandemic, but COVID-19 has magnified them.

The rehab staff estimates that Braganza will spend 10 to 14 days in their program, but discharge home creates a conundrum. Before becoming ill, Braganza lived in an independent senior living facility. Now, because of social distancing, he will no longer be able to hang out and have meals with his friends.

"Dad's already feeling really lonely in the hospital. If we stay on a semipermanent lock down, will he be able to see the people he loves?" Maria Braganza said. "Even though somebody is older, they have a lot to give and a lot of experience. They just need a little extra to be able to have that life."

Nolan, Chong, Mukhopadhyay, Miyakawa, Gholamrezanezhad, and Lubinsky report no relevant financial relationships.

Veronica Hackethal, MD, MSc, is a freelance medical journalist in Manhattan with expertise in public health. Her work has appeared in the New York Times, Scientific American, Nature Medicine News, Reuters Health, and others.

For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube.

The rest is here:
A Long Road to Recovery: Lung Rehab Needed After COVID-19 - Medscape

Read the Rest...

The impact of the coronavirus on the Microscope Slide Scanner Market : Dynamics, Segments, Size and Demand, 20192028 – Cole of Duty

§ May 26th, 2020 § Filed under Nano Medicine Comments Off on The impact of the coronavirus on the Microscope Slide Scanner Market : Dynamics, Segments, Size and Demand, 20192028 – Cole of Duty

Microscope Slide Scanner Market 2018: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2024

The report provides both quantitative and qualitative information of global Microscope Slide Scanner market for period of 2018 to 2025. As per the analysis provided in the report, the global market of Microscope Slide Scanner is estimated to growth at a CAGR of _% during the forecast period 2018 to 2025 and is expected to rise to USD _ million/billion by the end of year 2025. In the year 2016, the global Microscope Slide Scanner market was valued at USD _ million/billion.

This research report based on Microscope Slide Scanner market and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the Microscope Slide Scanner market that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players, demand and supply analysis as well as market share growth of the Microscope Slide Scanner industry.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2607155&source=atm

Microscope Slide Scanner Market Overview:

The Research projects that the Microscope Slide Scanner market size will grow from in 2018 to by 2024, at an estimated CAGR of XX%. The base year considered for the study is 2018, and the market size is projected from 2018 to 2024.

The report on the Microscope Slide Scanner market provides a birds eye view of the current proceeding within the Microscope Slide Scanner market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Microscope Slide Scanner market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Microscope Slide Scanner market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Leading manufacturers of Microscope Slide Scanner Market:

Market Segment Analysis The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Portable Microscope Slide Scanner Desktop Microscope Slide Scanner

Segment by Application Biological Research Medicine Veterinary Other

Global Microscope Slide Scanner Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Microscope Slide Scanner market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Microscope Slide Scanner Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019. The major players in the market include Feinoptic, Zeiss Microscopy, Roche, Biocompare, 3D Histech, Metasystems, Diapath, Histo-Line Laboratories, Olympus Microscopy Europa, Electron Microscopy Sciences, HEKA, Applied Spectral Imaging, Amos scientific, etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2607155&source=atm

Some important highlights from the report include:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2607155&licType=S&source=atm

The Questions Answered by Microscope Slide Scanner Market Report:

And Many More.

Link:
The impact of the coronavirus on the Microscope Slide Scanner Market : Dynamics, Segments, Size and Demand, 20192028 - Cole of Duty

Read the Rest...

How Coronavirus Pandemic Will Impact Sterile IV Containers Market 2025: Research By Top Manufacturers with Market Size,Market Growth, Competitive…

§ May 26th, 2020 § Filed under Nano Medicine Comments Off on How Coronavirus Pandemic Will Impact Sterile IV Containers Market 2025: Research By Top Manufacturers with Market Size,Market Growth, Competitive…

Analysis of the Global Sterile IV Containers Market

The report on the global Sterile IV Containers market reveals that the market is expected to grow at a CAGR of ~XX% during the considered forecast period (2019-2029) and estimated to reach a value of ~US$XX by the end of 2029. The latest report is a valuable tool for stakeholders, established market players, emerging players, and other entities to devise effective strategies to combat the impact of COVID-19

Further, by leveraging the insights enclosed in the report, market players can devise concise, impactful, and highly effective growth strategies to solidify their position in the Sterile IV Containers market.

Research on the Sterile IV Containers Market Addresses the Following Queries

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2678697&source=atm

Competitive Landscape

The competitive landscape section offers valuable insights related to the business prospects of leading market players operating in the Sterile IV Containers market. The market share, product portfolio, pricing strategy, and growth strategies adopted by each market player is included in the report. The major steps taken by key players to address the business challenges put forward by the novel COVID-19 pandemic is discussed in the report.

Regional Landscape

The regional landscape section provides a deep understanding of the regulatory framework, current market trends, opportunities, and challenges faced by market players in each regional market. The various regions covered in the report include:

End-User Assessment

The report bifurcates the Sterile IV Containers market based on different end users. The supply-demand ratio and consumption volume of each end-user is accurately depicted in the report.

Segment by Type, the Sterile IV Containers market is segmented into Pour Bottles Flexible Bags

Segment by Application Hospital Clinic Ambulatory Care Centres Others

Global Sterile IV Containers Market: Regional Analysis The Sterile IV Containers market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Sterile IV Containers market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

Global Sterile IV Containers Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Sterile IV Containers market include: B. Braun Medical Renolit Kraton Corporation Angiplast Baxter Fresenius Kabi Group. Sippex Guangdong lejin medicine Co.Ltd Medline Industries Pfizer (Hospira) Vioser SA

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2678697&source=atm

Essential Findings of the Sterile IV Containers Market Report:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2678697&licType=S&source=atm

Read more:
How Coronavirus Pandemic Will Impact Sterile IV Containers Market 2025: Research By Top Manufacturers with Market Size,Market Growth, Competitive...

Read the Rest...

COVID-19: Potential impact on Ready To Use Goji Berries Market Global Industry Analysis and Forecast Till 2023 – 3rd Watch News

§ May 26th, 2020 § Filed under Nano Medicine Comments Off on COVID-19: Potential impact on Ready To Use Goji Berries Market Global Industry Analysis and Forecast Till 2023 – 3rd Watch News

Detailed Study on the Global Goji Berries Market

A recent market study throws light on some of the leading factors that are likely to influence the growth of the Goji Berries market in the upcoming decade. The well-researched market study touches upon the growth potential of various budding market players in the current Goji Berries market landscape. Moreover, established players, stakeholders, and investors can leverage the data in the report to formulate effective growth strategies.

As per the report, the Goji Berries market is forecasted to reach a value of ~US$XX by the end of 2029 and grow at a CAGR of ~XX% through the forecast period (2019-2029). The key dynamics of the Goji Berries market including the drivers, restraints, opportunities, and trends are thoroughly analyzed in the presented report.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2608324&source=atm

The Research Aims to Addresses the Following Doubts Pertaining to the Goji Berries Market

The report on the Goji Berries market provides a birds eye view of the current proceeding within the Goji Berries market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Goji Berries market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Goji Berries market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2608324&source=atm

Goji Berries Market Segmentation

Competitive Landscape

The competitive landscape section of the report elaborates on the recent developments and innovations introduced by prominent players in the Goji Berries market. The growth potential, revenue growth, product range, and pricing strategies of each market player in inspected in the report with precision.

End-use Industry Assessment

The report segments the Goji Berries market on the basis of end-use industry and offers a detailed understanding of the supply-demand ratio and consumption pattern of the Goji Berries in each end-use industry.

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Goji Berries market is segmented into Black Goji Red Goji

Segment by Application Medicine Industry Food Industry Others

Global Goji Berries Market: Regional Analysis The Goji Berries market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Goji Berries market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Goji Berries Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Goji Berries market include: Organicway Viva Alovitox Essential Living Vantasty Unicorn Superfoods Ningxia Pure Goji Biology Technology

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2608324&licType=S&source=atm

Essential Findings of the Goji Berries Market Report:

Go here to read the rest:
COVID-19: Potential impact on Ready To Use Goji Berries Market Global Industry Analysis and Forecast Till 2023 - 3rd Watch News

Read the Rest...

Fluorinated Ethylene Propylene Market Will Expect Consumption of over 40 Kilo Tons by 2025 : Leading Key Players 3M, DowDuPont, Daikin Industries,…

§ May 26th, 2020 § Filed under Nanotechnology Journal Comments Off on Fluorinated Ethylene Propylene Market Will Expect Consumption of over 40 Kilo Tons by 2025 : Leading Key Players 3M, DowDuPont, Daikin Industries,…

Whats driving the Fluorinated Ethylene Propylene Market growth? | Leading Key Players 3M, DowDuPont, Daikin Industries, Ltd., Shanghai, F New Materials Co. Ltd., Saint-Gobain, Merck Millipore

This press release was orginally distributed by SBWire

Ocean View, DE -- (SBWIRE) -- 05/26/2020 -- Global Fluorinated Ethylene Propylene Market is anticipated to witness prominent growth on account of its increasing applications in the construction, renewable energy, automotive, chemical processing, and electrical & electronics industries. The product exhibits properties like greater breakdown voltage, longer life and good mechanical strength, making its application vital in electrical cable and wires that are used in power distribution lines.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3263

Frontrunners in the Fluorinated Ethylene Propylene Market - 3M - DowDuPont - Daikin Industries, Ltd. - Shanghai - F New Materials Co. Ltd. - Saint-Gobain - Merck Millipore - The Chemours Company - Juhua Group Corporation - AMETEK, Inc. - Polyfluor Plastics B.V. - BASF - ITAFLON - Shandong Hengyi New Material Technology - Inoflon Fluoropolymers

A noticeable rise in government initiatives to expand existing power distribution networks may fuel the demand for fluorinated ethylene propylene. Moreover, commencement of new building infrastructures and rapid urbanization may drive the demand for wires and cables, thereby augmenting FEP market size. On this note, Global Market Insights, Inc., suggests that the fluorinated ethylene propylene market is anticipated to amass around USD 1.2 billion by 2025.

Request For Discount of this Report: https://www.gminsights.com/request-discount/3263

A surge in the vehicle manufacturing may bolster product demand in the automobile sector. Moreover, rise in military spending and air passenger traffic worldwide would supplement fluorinated ethylene propylene market outlook in the forthcoming years.

FEP finds extensive applications in the chemical processing industry as well, owing to its properties like low coefficient of friction, desirable chemical resistance, and nonstick functionalities. Intensifying demand for advanced chemicals in the construction and oil & gas industry might fuel the demand for FEP in applications like gaskets, vessel liners, tubing, fluid handling systems, and valves.

Moreover, surging investment in research & development, increasing requirement for advanced materials in the automotive sector and rising adoption of nanotechnology are projected to propel FEP market share. Studies suggest that the global fluorinated ethylene propylene would record growth of over 6.5% from chemical processing applications over the estimated timeframe.

In terms of regional share, North America fluorinated ethylene propylene market is expected to witness considerable growth owing to rapid advancements in the renewable energy sector. The product is used in the manufacturing of solar cells due to its low weight, long life, weathering performance, and UV resistance. The advent of new government initiatives focused on reducing greenhouse gas emissions, increasing demand for self-sufficiency, and offering of subsidies on installation photovoltaic systems are anticipated to shape the growth trajectory for North America fluorinated ethylene propylene market growth.

It is vital to mention that the fluorinated ethylene propylene market is highly competitive, with companies like Daikin Industries, 3M, DowDuPont, Saint-Gobain, and Merck Millipore dominating the global industry. These firms are introducing new products to enhance their offering and attract new customers.

For more information on this press release visit: http://www.sbwire.com/press-releases/fluorinated-ethylene-propylene-market-will-expect-consumption-of-over-40-kilo-tons-by-2025-leading-key-players-3m-dowdupont-daikin-industries-ltd-shanghai-1292369.htm

Here is the original post:

Fluorinated Ethylene Propylene Market Will Expect Consumption of over 40 Kilo Tons by 2025 : Leading Key Players 3M, DowDuPont, Daikin Industries,...

Read the Rest...

COVID-19 Impact on Global Complementary and Alternative Medicine Market Size, Status and Forecast 2020-2026 – 3rd Watch News

§ May 26th, 2020 § Filed under Quantum Medicine Comments Off on COVID-19 Impact on Global Complementary and Alternative Medicine Market Size, Status and Forecast 2020-2026 – 3rd Watch News

In this report, the COVID-19 Impact on Global Complementary and Alternative Medicine market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. COVID-19 Impact on Global Complementary and Alternative Medicine market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/covid-19-impact-on-global-complementary-and-alternative-medicine-market-size-status-and-forecast-2020-2026

Complementary medicineis treatments that are used along with standard medical treatments but are not considered to be standard treatments. One example is using acupuncture to help lessen some side effects of cancer treatment.Alternative medicine is treatments that are used instead of standard medical treatments. One example is using a special diet to treat cancer instead of anticancer drugs that are prescribed by an oncologist.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Complementary and Alternative Medicine market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Complementary and Alternative Medicine industry.

Based on our recent survey, we have several different scenarios about the Complementary and Alternative Medicine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Complementary and Alternative Medicine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Complementary and Alternative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Complementary and Alternative Medicine market in terms of revenue.

Players, stakeholders, and other participants in the global Complementary and Alternative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Complementary and Alternative Medicine market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Complementary and Alternative Medicine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Complementary and Alternative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Complementary and Alternative Medicine market.

The following players are covered in this report:

Columbia Nutritional

Herb Pharm

Herbal Hills

Helio USA

Deepure Plus

Nordic Naturals

Pure encapsulations

Iyengar Yoga Institute

John Schumachers Unity Woods Yoga Center

Yoga Tree

The Healing Company

Quantum Touch

Complementary and Alternative Medicine Breakdown Data by Type

Botanicals

Acupuncture

Mind, Body, and Yoga

Magnetic Intervention

Complementary and Alternative Medicine Breakdown Data by Application

Direct Contact

E-training

Distance Correspondence

Browse full research report at https://www.crystalmarketreport.com/covid-19-impact-on-global-complementary-and-alternative-medicine-market-size-status-and-forecast-2020-2026

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 911 Central Avenue #268 Albany New York 12206 Email: [emailprotected] Phone: 1-518-730-1569 Web: https://www.crystalmarketreport.com

Here is the original post:

COVID-19 Impact on Global Complementary and Alternative Medicine Market Size, Status and Forecast 2020-2026 - 3rd Watch News

Read the Rest...

Potential Impact of COVID-19 on Complementary and Alternative Medicine Market Analysis on Current Trends by 2028 – Cole of Duty

§ May 26th, 2020 § Filed under Quantum Medicine Comments Off on Potential Impact of COVID-19 on Complementary and Alternative Medicine Market Analysis on Current Trends by 2028 – Cole of Duty

The report on the Complementary and Alternative Medicine market provides a birds eye view of the current proceeding within the Complementary and Alternative Medicine market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Complementary and Alternative Medicine market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Complementary and Alternative Medicine market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Complementary and Alternative Medicine market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands. Complementary and Alternative Medicine market reports provides all data with easily digestible information to guide every businessmans future innovation and move business forward.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2601857&source=atm

The worldwide Complementary and Alternative Medicine market is an enlarging field for top market players,

The key players covered in this study Columbia Nutritional Herb Pharm Herbal Hills Helio USA Deepure Plus Nordic Naturals Pure encapsulations Iyengar Yoga Institute John Schumachers Unity Woods Yoga Center Yoga Tree The Healing Company Quantum Touch

Market segment by Type, the product can be split into Botanicals Acupuncture Mind, Body, and Yoga Magnetic Intervention Market segment by Application, split into Direct Contact E-training Distance Correspondence

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Complementary and Alternative Medicine status, future forecast, growth opportunity, key market and key players. To present the Complementary and Alternative Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Complementary and Alternative Medicine are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2601857&source=atm

This Complementary and Alternative Medicine report begins with a basic overview of the market. The analysis highlights the opportunity and Complementary and Alternative Medicine industry trends that are impacted the market that is global. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Complementary and Alternative Medicine insight regarding the things which are driving and affecting the earnings of the market. The Complementary and Alternative Medicine report comprises sections together side landscape which clarifies actions such as venture and acquisitions and mergers.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2601857&licType=S&source=atm

Research objectives and Reason to procure this report:-

Finally, the global Complementary and Alternative Medicine market provides a total research decision and also sector feasibility of investment in new projects will be assessed. Complementary and Alternative Medicine industry is a source of means and guidance for organizations and individuals interested in their market earnings.

Link:

Potential Impact of COVID-19 on Complementary and Alternative Medicine Market Analysis on Current Trends by 2028 - Cole of Duty

Read the Rest...

Amid the COVID-19 crisis and the looming economic recession, the Nanotechnology in Drug Delivery market worldwide will grow by a projected US$124.7…

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Amid the COVID-19 crisis and the looming economic recession, the Nanotechnology in Drug Delivery market worldwide will grow by a projected US$124.7…

May 26, 2020 12:52 ET | Source: ReportLinker

New York, May 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nanotechnology in Drug Delivery Industry" - https://www.reportlinker.com/p05621749/?utm_source=GNW 1 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Nanocrystals market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 17% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$4.1 Billion to the regions size over the next 7 to 8 years. In addition, over US$3.7 Billion worth of projected demand in the region will come from Rest of European markets. In Japan, the Nanocrystals segment will reach a market size of US$3 Billion by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Nanotechnology in Drug Delivery market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the worlds second largest economy will grow at 25.2% over the next couple of years and add approximately US$20.2 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Nanotechnology in Drug Delivery market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, AbbVie Inc.; Aquanova AG; BlueWillow Biologics; Camurus AB; Celgene, Inc.; Ceramisphere Health Pty Limited; Cristal Therapeutics; CYTIMMUNE SCIENCES, Inc.; EnColl Corporation; EyePoint Pharmaceuticals; Lena Nanoceutics Ltd.; Nanobiotix; NanoCarrier Co., Ltd.; NanOlogy LLC; Nanospectra Biosciences, Inc.; Parvus Therapeutics Inc.; Selecta Biosciences; Starpharma Holdings Limited; Taiwan Liposome Co., ; Tarveda Therapeutics

Read the full report: https://www.reportlinker.com/p05621749/?utm_source=GNW

NANOTECHNOLOGY IN DRUG DELIVERY MCP-7 MARKET ANALYSIS, TRENDS, AND FORECASTS, JUNE 2 CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Nanotechnology, A Critical Part of Healthcare Reform Recent Market Activity Nanomedicine, Revolutionizing the Basics of Medicine A Peek Into the Evolving Role of Nanoparticles in Nanomedicine Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems Nanotechnology-Based Strategies for siRNA Grows in Popularity NEM Devices as Drug Delivery Vehicles Nanotechnology - In Pursuit of Co-Delivery of Drugs Nanoemulsions Begin to Make a Mark Nanotechnology Finds Increasing Role in Fighting Infectious Diseases List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use Nanotechnology Opening New Avenues in Antiretroviral Therapy Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies Nanotechnology in Delivery of CNS Therapeutics Market Outlook Global Competitor Market Shares Nanotechnology in Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS AbbVie Inc. (USA) Aquanova AG (Germany) BlueWillow Biologics (USA) Camurus AB (Sweden) Celgene, Inc. (Canada) Ceramisphere Health Pty Limited (Australia) Cristal Therapeutics (The Netherlands) CYTIMMUNE SCIENCES, INC. (Italy) EnColl Corporation (USA) EyePoint Pharmaceuticals (USA) Lena Nanoceutics Ltd. (UK) NanOlogy LLC (USA) NanoCarrier Co., Ltd. (Japan) Nanobiotix (France) Nanospectra Biosciences, Inc (USA) Parvus Therapeutics Inc. (USA) Selecta Biosciences (USA) Starpharma Holdings Limited (Australia) Taiwan Liposome Co. (Taiwan) Tarveda Therapeutics (USA) 3. MARKET TRENDS & DRIVERS Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs Inorganic Nanocarriers Facilitate High Payload Capacity and Co -Delivery Platforms for MDR Cancer Therapy Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery SLNs in Pulmonary Delivery of Drugs Market Challenges Increasing Environmental and Health Concerns Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement Higher Concentration of Research in Academia limits Commercialization Collaborations Assume Importance Nanomedicine Regulation 4. GLOBAL MARKET PERSPECTIVE Table 1: Nanotechnology in Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Nanotechnology in Drug Delivery Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 Table 3: Nanocrystals (Technology) World Market by Region/Country in US$ Million: 2020 to 2027 Table 4: Nanocrystals (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 Table 5: Nanocarriers (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 Table 6: Nanocarriers (Technology) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Nanotechnology in Drug Delivery Market Share (in %) by Company: 2020 & 2025 Market Analytics Table 7: Nanotechnology in Drug Delivery Market in US$ Million in the United States by Technology: 2020-2027 Table 8: United States Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 CANADA Table 9: Nanotechnology in Drug Delivery Market Analysis in Canada in US$ Million by Technology: 2020-2027 Table 10: Canadian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 JAPAN Table 11: Japanese Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 12: Japanese Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 CHINA Table 13: Nanotechnology in Drug Delivery Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027 Table 14: Nanotechnology in Drug Delivery Market in China: Percentage Share Analysis by Technology for 2020 and 2027 EUROPE Market Facts & Figures European Nanotechnology in Drug Delivery Market: Competitor Market Share Scenario (in %) for 2020 & 2025 Market Analytics Table 15: European Nanotechnology in Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025 Table 16: European Nanotechnology in Drug Delivery Market Share Shift by Region/Country: 2020 VS 2027 Table 17: European Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 18: Nanotechnology in Drug Delivery Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027 FRANCE Table 19: French Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027 Table 20: French Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 GERMANY Table 21: German Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 22: German Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 ITALY Table 23: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027 Table 24: Nanotechnology in Drug Delivery Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027 UNITED KINGDOM Table 25: United Kingdom Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 26: United Kingdom Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 SPAIN Table 27: Nanotechnology in Drug Delivery Market Analysis in Spain in US$ Million by Technology: 2020-2027 Table 28: Spanish Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 RUSSIA Table 29: Nanotechnology in Drug Delivery Market in US$ Million in Russia by Technology: 2020-2027 Table 30: Russian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 REST OF EUROPE Table 31: Rest of Europe Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 32: Nanotechnology in Drug Delivery Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2 and 2027 ASIA-PACIFIC Table 33: Asia-Pacific Nanotechnology in Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 34: Asia-Pacific Nanotechnology in Drug Delivery Market Share Analysis by Region/Country: 2020 VS 2027 Table 35: Asia-Pacific Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027 Table 36: Asia-Pacific Nanotechnology in Drug Delivery Historic Market Analysis in US$ Million by Technology: 2020 VS 2027 AUSTRALIA Table 37: Australian Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 38: Australian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 INDIA Table 39: Nanotechnology in Drug Delivery Market Analysis in India in US$ Million by Technology: 2020-2027 Table 40: Indian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 SOUTH KOREA Table 41: Nanotechnology in Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020-2027 Table 42: Nanotechnology in Drug Delivery Market Share Distribution in South Korea by Technology: 2020 VS 2027 REST OF ASIA-PACIFIC Table 43: Rest of Asia-Pacific Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 44: Rest of Asia-Pacific Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 LATIN AMERICA Table 45: Latin American Nanotechnology in Drug Delivery Market Trends by Region/Country in US$ Million: 2020-2027 Table 46: Latin American Nanotechnology in Drug Delivery Market Percentage Breakdown of Sales by Region/Country: 2020 and 2027 Table 47: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Latin America in US$ Million by Technology: 2020-2027 Table 48: Nanotechnology in Drug Delivery Market in Latin America : Percentage Analysis by Technology for 2020 and 2027 ARGENTINA Table 49: Argentinean Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 50: Nanotechnology in Drug Delivery Market in Argentina: Percentage Breakdown of Sales by Technology for 2020 and 2027 BRAZIL Table 51: Brazilian Nanotechnology in Drug Delivery Market Estimates and Projections in US$ Million by Technology: 2020-2027 Table 52: Brazilian Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 MEXICO Table 53: Mexican Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 54: Mexican Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 REST OF LATIN AMERICA Table 55: Nanotechnology in Drug Delivery Market in US$ Million in Rest of Latin America by Technology: 2020-2027 Table 56: Rest of Latin America Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 MIDDLE EAST Table 57: The Middle East Nanotechnology in Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 58: The Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Region/Country: 2020 and 2027 Table 59: The Middle East Nanotechnology in Drug Delivery Market Analysis in US$ Million by Technology: 2020-2027 Table 60: The Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 IRAN Table 61: Iranian Medium & Long-Term Outlook for Nanotechnology in Drug Delivery Market in US$ Million by Technology: 2020-2027 Table 62: Iranian Nanotechnology in Drug Delivery Market Percentage Share Distribution by Technology: 2020 VS 2027 ISRAEL Table 63: Israeli Nanotechnology in Drug Delivery Market Assessment in US$ Million by Technology: 2020-2027 Table 64: Nanotechnology in Drug Delivery Market in Israel: Percentage Breakdown of Sales by Technology for 2020 and 2027 SAUDI ARABIA Table 65: Nanotechnology in Drug Delivery Market Estimates and Forecasts in Saudi Arabia in US$ Million by Technology: 2020-2027 Table 66: Nanotechnology in Drug Delivery Market in Saudi Arabia: Percentage Share Analysis by Technology for 2020 and 2027 UNITED ARAB EMIRATES Table 67: Nanotechnology in Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020-2027 Table 68: Nanotechnology in Drug Delivery Market Share Distribution in United Arab Emirates by Technology: 2020 VS 2027 REST OF MIDDLE EAST Table 69: Rest of Middle East Nanotechnology in Drug Delivery Latent Demand Forecasts in US$ Million by Technology: 2020-2027 Table 70: Rest of Middle East Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 AFRICA Table 71: Nanotechnology in Drug Delivery Market in US$ Million in Africa by Technology: 2020-2027 Table 72: African Nanotechnology in Drug Delivery Market Share Breakdown by Technology: 2020 VS 2027 IV. COMPETITION

Total Companies Profiled: 43 Read the full report: https://www.reportlinker.com/p05621749/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Lyon, FRANCE

Formats available:

Originally posted here:

Amid the COVID-19 crisis and the looming economic recession, the Nanotechnology in Drug Delivery market worldwide will grow by a projected US$124.7...

Read the Rest...

The Evolution of Solar Technology – How Photovoltaic Technology Has Developed and Why Nanotechnology May Influence the Future – AltEnergyMag

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on The Evolution of Solar Technology – How Photovoltaic Technology Has Developed and Why Nanotechnology May Influence the Future – AltEnergyMag

Here, Dr Franky So, chief technology officer of nanotechnology research company Nextgen Nano, explains the historical developments of photovoltaic technology and looks to the innovations shaping the years ahead.

Dr Franky So, CTO | NextGen Nano

In days gone by, many ancient civilisations from the Aztecs to ancient Egyptians worshipped the Sun as a god or deity that could bestow prosperity and maintain the order of the day-night cycle. In the slightly more enlightened times of today, we look to the Sun once more; not as a deity, but as a sustainable source of energy, if only we can harness it effectively. Here, Dr Franky So, chief technology officer of nanotechnology research company Nextgen Nano, explains the historical developments of photovoltaic technology and looks to the innovations shaping the years ahead.

As the closest star to Earth, we owe a lot to the Sun. Not only does it keep us and our cosmic neighbours in a generally consistent orbit that fosters the conditions for life as we know it, but it also provides us with an immense source of energy. Every hour of the day, the Sun hits the Earth with 430 quintillion joules of energy. This is a tremendous amount of energy. For context, if we were able to harness all this energy as electricity, it would be enough to satisfy the worlds global energy demands.

Realising this, the opportunity presented for solar technology is equally tremendous. Since the photovoltaic (PV) effect was first observed by Edmond Becquerel in 1839, weve become aware of the ways humankind can harness the energy expelled by the sun on a daily basis. PV panels have been our primary means of doing that since their invention in 1954, with varying degrees of success and efficiency.

However, recent years have driven greater research into highly efficient and commercially viable PV technology. Humanity has collectively accelerated the depletion of natural resources for use as energy sources, and the changes to the environment linked to the use of these resources, has increased the need for sustainable energy generation.

There are three specific processes that need to take place in PV cells for them to function properly. First, the cells need to absorb photons in semiconducting materials. Then, these photons excite charge carriers in the semiconductor material, which subsequently are extracted from the cell to electrodes, resulting in electrical current generation. To convert this current to electricity, the generated direct current (DC) goes through to inverters is converted alternating current (AC) for consumption.

The first PV cell that achieved solar energy harvesting was produced by Bell Labs in 1954. This panel converted sunlight to electricity with a six per cent efficiency, meaning it only successfully turned a small fraction of the photons that hit it into electricity. Nevertheless, it marked the birth of the first-generation solar technology.

First generation PV panels consisted of wafer-based cells, which were typically made using materials such as crystalline silicon. The overall design of these panels was based around that of a single p-n junction, where positive (p) and negative (n) type semiconductor materials form a junction. In an n-doped material, negative charges are present, and positive charges are present in the p-doped layer. This generates an electric field at the junction between the layers, which pushes photo-generated charge carriers out of the p-n junction and towards the electrodes.

Developments continued into the 21st century, with a solar cell being created that exhibited 33 per cent efficiency in laboratory environments in 1999. The second generation solar technology was born in the 1980s, promising to overcome some of the technical and physical limitations introduced by their predecessors 30 years ago.

Where the first generation was primarily silicon based, this new generation cells uses a more diverse range of materials, ranging from amorphous silicon cells to cadmium telluride. Because of the strong light absorption comparing with silicon, these are thin-film solar cells because thin layers of these materials can be deposited onto substrate materials such as glass or plastic.

The key difference between the two generations is that the slimmer footprint of the latters cells allowed for new PV panel designs that could circumvent the theoretical Shockley-Queisser limit. This is predominately achieved by introducing multiple photoactive materials to create multi-junction cells and extend the spectral response of the final cell and increase the power conversion efficiency.

Of course, second generation solar has its own practical limitations. The substrate materials in second generation PV panels are still inflexible and, with current efficiencies being in the region of 20 to 30 per cent depending on footprint and materials, require substantial surface areas. In addition, some of the materials used such as cadmium, which is noted as carcinogenic to humans can produce toxic by-products during recycling or when exposed to certain environmental conditions.

This poses a challenge for the design of PV panels. In addition to being a sustainable energy source, it would be ideal if solar panels were environmentally-friendly and non-toxic to humans and the environment alike. This has spurred research into third generation solar and research looks promising.

The third generation of solar technology incorporates several types of solar technologies, most notably organic photovoltaic (OPV) cells that aim to provide greater efficiency while reducing the overall environmental impact of PV panels. This is the technology that the team of researchers at Nextgen Nano has been exploring, with the goal of using nanotechnology to develop a highly efficient, flexible organic solar cells that supports efforts to decentralise energy generation.

The result of this research is PolyPower, which blends earth-friendly organic materials to provide a lightweight, flexible and potentially inexpensive approach to solar energy harvesting. This technology achieves these characteristics while still being robust, mitigating the problems associated with brittle panels.

In fact, because PolyPower is developed at a nano level with transparency and flexibility, it can effectively be applied as semi-transparent thin layer to the surface of buildings, windows and even the roof-top of a vehicle. These applications could feature organic polymer solar cells as a design feature, allowing them to charge during outdoor usage, independent of a centralised power supply.

This is where we see the future of solar technology going. Historically, PV panels have been largely limited due to their mechanical properties. The next generation of solar can overcome these challenges and open a world of possibilities, with the use of nanotechnology. The opportunities presented mean we can effectively use solar energy in applications where they have not previously been viable.

We no longer worship the Sun as a sacred deity, but there is no understating the importance of it in the future of energy generation. It is, in essence, a cosmic battery boasting practically bottomless energy and with half of its (approximately) ten billion year run time remaining. All we need is the right technology to harness this potential energy, in a way that is ethical, environmentally friendly and adaptable to the applications and industries that will emerge in the years ahead.

AboutNextGen Nano NextGen Nanos breakthrough technology replaces existing solutions which are fabricated with pollutant materials with earth-friendly organic materials. This breakthrough enables NextGen Nano to develop solar cells that produce energy with unrivalled efficiency, at far lower cost than existing hardware. The technology can be applied to flexible surfaces, thus making the limitless solar power source more usable and cost effective than ever before.

This post does not have any comments. Be the first to leave a comment below.

You must be logged in before you can post a comment. Login now.

Extract maximum power production from every roof size and shape. HIT AC Series combines the module efficiency of Panasonic solar panels with the intelligence of Enphase microinverters. A built-in IQ 7X microinverter with Individual MPPT (Module-level Power Point Tracker) tracking helps deliver an all-in-one module that offers design flexibility, reduced installation time, and a higher ROI. Field-replaceable microinverter with no DC wire management required yields lower cost of ownership.

Read more from the original source:

The Evolution of Solar Technology - How Photovoltaic Technology Has Developed and Why Nanotechnology May Influence the Future - AltEnergyMag

Read the Rest...

Coronavirus threat to global Nanotechnology in Medical Equipment Market : Analysis and In-depth Study on Nanotechnology in Medical Equipment Market…

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Coronavirus threat to global Nanotechnology in Medical Equipment Market : Analysis and In-depth Study on Nanotechnology in Medical Equipment Market…

The report on the Nanotechnology in Medical Equipment market provides a birds eye view of the current proceeding within the Nanotechnology in Medical Equipment market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Nanotechnology in Medical Equipment market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Nanotechnology in Medical Equipment market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.

The Nanotechnology in Medical Equipment market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the Nanotechnology in Medical Equipment market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2657645&source=atm

The major players profiled in this Nanotechnology in Medical Equipment market report include:

The key players covered in this study Stryker Corporation 3M Abbott Thermo Fisher Scientific PerkinElmer, Inc. Starkey Hearing Technologies Smith + Nephew Dentsply International Mitsui Chemicals, Inc. AAP Implantate AG

Market segment by Type, the product can be split into Active Implantable Medical Equipments Biochip Portable Material Market segment by Application, split into Treatment Using Diagnostic Using Research Using

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Nanotechnology in Medical Equipment status, future forecast, growth opportunity, key market and key players. To present the Nanotechnology in Medical Equipment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nanotechnology in Medical Equipment are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2657645&licType=S&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2657645&source=atm

The rest is here:

Coronavirus threat to global Nanotechnology in Medical Equipment Market : Analysis and In-depth Study on Nanotechnology in Medical Equipment Market...

Read the Rest...

Nanotechnology in Cancer Treatment Market 2020 Industry Size, Growth, Share, Trends, Companies, Comprehensive Research and Forecast to 2026 – Cole of…

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Nanotechnology in Cancer Treatment Market 2020 Industry Size, Growth, Share, Trends, Companies, Comprehensive Research and Forecast to 2026 – Cole of…

Global Nanotechnology in Cancer Treatment Market Research Report 2020 provides the market size information, in-depth analysis along with competitive insights and segmentation. Additionally, this Report explorers Nanotechnology in Cancer Treatment market size, trends, share, growth, development plans, Investment Plan, cost structure and drivers analysis.

Get Sample Copy of this Report at https://www.orianresearch.com/request-sample/1599992

This report contains the major manufacturers analysis of the global Nanotechnology in Cancer Treatment industry. By understanding the operations of these manufacturers (sales volume, revenue, sales price and gross margin from 2015 to 2020), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.

Key STRATEGIC MANUFACTURERS include in this report:-

Abbott Laboratories

Combimatrix Corporation

GE Healthcare

Sigma-Tau Pharmaceuticals Inc.

Johnson & Johnson

Mallinckrodt Plc

Merck & Company Inc.

Nanosphere Inc.

Pfizer, Inc.

Celgene Corporation

Development policies and plans are discussed as well as growth rate, manufacturing processes, economic growth and worldwide strategies are analyzed. This Nanotechnology in Cancer Treatment Research Report also states import/export data, industry supply and consumption figures as well as cost structure, price, industry revenue and gross margin by regions.

This report studies the Nanotechnology in Cancer Treatment market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Nanotechnology in Cancer Treatment industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Nanotechnology in Cancer Treatment industry.

Global Nanotechnology in Cancer Treatment market: types and end industries analysis

The research report includes specific segments such as end industries and product types of Nanotechnology in Cancer Treatment. The report provides market size (sales volume and revenue) for each type and end industry from 2015 to 2020. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global Nanotechnology in Cancer Treatment market: regional analysis

Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Nanotechnology in Cancer Treatment in these countries from 2015 to 2020, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.

Market segment by Type, the product can be split into Nanoparticles Nanorods Nanofibers Graphene Metal-Organic Frameworks Nanobiosensors Nanofluidic Devices Nanotools Market segment by Application, split into Cancer Detection Imaging Drug Delivery Radiotherapy Immunotherapy Phototherapy

Order a Copy of Global Nanotechnology in Cancer Treatment Market Report @ https://www.orianresearch.com/checkout/1599992

Finally, the Report provides detailed profile and data information analysis of leading companies.

Major Points from Table of Contents-

1 Industry Overview of Nanotechnology in Cancer Treatment

2 Major Manufacturers Analysis of Nanotechnology in Cancer Treatment Industry

3 Global Nanotechnology in Cancer Treatment Market Analysis by Regions, Manufacturers, Types and End Users

4 North America Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

5 Europe Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

6 Asia Pacific Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

7 Latin America Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

8 Middle East & Africa Nanotechnology in Cancer Treatment Market Analysis by Countries, Types and End Users

9 Marketing Channel, Distributors and Traders Analysis

10 Global Nanotechnology in Cancer Treatment Market Forecast by Regions, Countries, Manufacturers, Types and End Users

11 Industry Chain Analysis of Nanotechnology in Cancer Treatment

12 Nanotechnology in Cancer Treatment New Project Investment Feasibility Analysis

13 Nanotechnology in Cancer Treatment Research Findings and Conclusion

14 Appendix

Note: We can also customize this record and provide individual chapters or a region-wise breakdown record such as North America, Europe or Asia. Also, if you have any special requirements, please let us know and we will offer you the record as you want.

About Us:

Orian Research is one of the most comprehensive collections of market intelligence records on the World Wide Web. Our records repository boasts of over 500000+ industry and country research from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:-

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Read more from the original source:

Nanotechnology in Cancer Treatment Market 2020 Industry Size, Growth, Share, Trends, Companies, Comprehensive Research and Forecast to 2026 - Cole of...

Read the Rest...

New 5G Switches Mean Battery Life Improvements, Higher Bandwidth and Speeds – UT News | The University of Texas at Austin

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on New 5G Switches Mean Battery Life Improvements, Higher Bandwidth and Speeds – UT News | The University of Texas at Austin

AUSTIN, Texas The 5G revolution has begun, and the first lines of phones that can access the next generation of wireless speeds have already hit the shelves. Researchers at The University of Texas at Austin and the University of Lille in France have built a new component that will more efficiently allow access to the highest 5G frequencies in a way that increases devices battery life and speeds up how quickly we can do things like stream high-definition media.

Smartphones are loaded with switches that perform a number of duties. One major task is jumping between networks and spectrum frequencies: 4G, Wi-Fi, LTE, Bluetooth, etc. The current radio-frequency (RF) switches that perform this task are always running, consuming precious processing power and battery life.

The switch we have developed is more than 50 times more energy efficient compared to what is used today, said Deji Akinwande, a professor in the Cockrell School of Engineerings Department of Electrical and Computer Engineering who led the research. It can transmit an HDTV stream at a 100 gigahertz frequency, and that is unheard of in broadband switch technology.

Akinwande and his research team published their findings today in the journal Nature Electronics.

It has become clear that the existing switches consume significant amounts of power, Akinwande said. And that power consumed is useless power.

The new switches stay off, saving battery life for other processes, unless they are actively helping a device jump between networks. They have also shown the ability to transmit data well above the baseline for 5G-level speeds.

The U.S. Defense Advanced Research Projects Agency (DARPA) has for years pushed for the development of near-zero-power RF switches. Prior researchers have found success on the low end of the 5G spectrum where speeds are slower but data can travel longer distances. But, this is the first switch that can function across the spectrum from the low-end gigahertz (GHz) frequencies to high-end terahertz (THz) frequencies that could someday be key to the development of 6G.

The UT teams switches use the nanomaterial hexagonal boron nitrite (hBN). It is an emerging nanomaterial from the same family as graphene, the so-called wonder material. The structure of the switch involves a single layer of boron and nitrogen atoms in a honeycomb pattern, which Akinwande said is almost 1 million times thinner than human hair, sandwiched between a pair of gold electrodes.

The impact of these switches extends beyond smartphones. Satellite systems, smart radios, reconfigurable communications, the internet of things and defense technology are all examples of other potential uses for the switches.

Radio-frequency switches are pervasive in military communication, connectivity and radar systems, said Dr. Pani Varanasi, division chief of the materials science program at the Army Research Office, an element of the U.S. Army Combat Capabilities Development Commands Army Research Laboratory that helped fund the project. These new switches could provide large performance advantage compared to existing components and can enable longer battery life for mobile communication, and advanced reconfigurable systems.

This research spun out of a previous project that created the thinnest memory device ever producedalso using hBN. Akinwande said sponsors encouraged the researchers to find other uses for the material, and that led them to pivot to RF switches.

The UT team includes electrical and computer engineering professor Jack Lee and graduate students Myungsoo Kim, Ruijing Ge and Xiaohan Wu. They worked with researchers at the University of Lilles Institute of Electronics, Microelectronics and Nanotechnology, led by Emiliano Pallecchi and Henri Happy.

The research was funded through grants from the U.S. Office of Naval Research, the Army Research Office, and an Engineering Research Center funded by the National Science Foundation. Fabrication of the switch was partly done at the Texas Nanofabrication Facility, and hBN samples were provided by Grolltex Inc.

See the original post here:

New 5G Switches Mean Battery Life Improvements, Higher Bandwidth and Speeds - UT News | The University of Texas at Austin

Read the Rest...

Nanotechnology in Energy Market is Thriving Worldwide By Size, Revenue, Emerging Trends and Top Growing… – Azizsalon News

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Nanotechnology in Energy Market is Thriving Worldwide By Size, Revenue, Emerging Trends and Top Growing… – Azizsalon News

This detailed market study covers nanotechnology in energy market growth potentials which can assist the stake holders to understand key trends and prospects in nanotechnology in energy market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the markets growth potential, which can help investors identify scope and opportunities. The analysis also provides details of each segment in the global nanotechnology in energy market

Click Here to Get Sample of the Premium Report @ https://www.quincemarketinsights.com/request-sample-62545?utm_source=AZ&utm_medium=Arshad

According to the report, the nanotechnology in energy market report points out national and global business prospects and competitive conditions for Nanotechnology in energy. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for Nanotechnology in energy. The Nanotechnology in energy market has been segmented by material (nanostructured material, carbon nanotubes, fullerenes and others), by application (electrical (transmission and storage), manufacturing, renewable and nonrenewable energy production, others. Historical background for the demand of Nanotechnology in energy has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand Nanotechnology in energy have also been established with potential gravity.

This report provides: 1) An overview of the global market for nanotechnology in energy market and related technologies. 2) Analysis of global market trends, yearly estimates and annual growth rate projections for compounds (CAGRs). 3) Identification of new market opportunities and targeted consumer marketing strategies for global nanotechnology in energy market . 4) Analysis of R&D and demand for new technologies and new applications 5) Extensive company profiles of key players in industry.

The researchers have studied the market in depth and have developed important segments such as product type, application and region. Each and every segment and its sub-segments are analyzed based on their market share, growth prospects and CAGR. Each market segment offers in-depth, both qualitative and quantitative information on market outlook.

Regional segmentation and analysis to understand growth patterns: The market has been segmented in major regions to understand the global development and demand patterns of this market.

Detailed information for markets like North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World is provided by the global outlook for nanotechnology in energy market . During the forecast period, North America and Western Europe are projected as main regions for nanotechnology in energy market . As one of the developed regions, the energy & power sector is important for the operations of different industries in this area

This is one of the key factors regulating nanotechnology in energy market growth in those regions. Some of the major countries covered in this region include the USA, Germany, United Kingdom, France, Italy, Canada, etc.

Make an Enquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-62545?utm_source=AZ&utm_medium=Arshad

During the forecast period Asia Pacific is expected to be one of the fastest growing regions for the nanotechnology in energy market . Some of the fastest-growing economies and increasing energy & power demand to cater for high population & industries are expected to drive demand in this area. During the forecast period, China and India are expected to record large demand. During the forecast period, the Middle East which includes the UAE, Saudi Arabia, Iran, Qatar and others promises high market potential. In terms of market demand during the forecast period, the rest of the world including South America and Africa are developing regions.

With an emphasis on strategies there have been several primary developments done by major companies such as Nano Dimension, Ablynx, Advance reproductions corporation, Z-medica, LLC, InMat, Inc., APS material, Inc., SolarMar energy, Inc., Solar Botanic Ltd., Rogue Valley Micro.

Market Segmentation: By Material: o Nanostructured Material o Carbon Nanotubes o Fullerenes and Others

By Application: o Electrical o Transmission o and Storage o Manufacturing o Renewable and Nonrenewable energy production o Others

By Region: North America o North America, by Country o US o Canada o Mexico o North America, by Material o North America, by Application

Western Europe o Western Europe, by Country o Germany o UK o France o Italy o Spain o The Netherlands o Rest of Western Europe o Western Europe, by Material o Western Europe, by Application

Asia Pacific o Asia Pacific, by Country o China o India o Japan o South Korea o Australia o Indonesia o Rest of Asia Pacific o Asia Pacific, by Material o Asia Pacific, by Application

Eastern Europe o Eastern Europe, by Country o Russia o Turkey o Rest of Eastern Europe o Eastern Europe, by Material o Eastern Europe, by Application

Middle East o Middle East, by Country o UAE o Saudi Arabia o Qatar o Iran o Rest of Middle East o Middle East, by Material o Middle East, by Application

Rest of the World o Rest of the World, by Country o South America o Africa o Rest of the World, by Material o Rest of the World, by Application

Customization: This study is customized to meet your specific requirements: o By Segment o By Sub-segment o By Region/Country o Product Specific Competitive Analysis

Contact: Quince Market Insights Ajay D. (Knowledge Partner) Office No- A109 Pune, Maharashtra 411028 Phone: US +1 208 405 2835 UK +44 121 364 6144 APAC +91 706 672 4848 Email: sales@quincemarketinsights.com Web:www.quincemarketinsights.com

ABOUT US: QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

More:

Nanotechnology in Energy Market is Thriving Worldwide By Size, Revenue, Emerging Trends and Top Growing... - Azizsalon News

Read the Rest...

C-Bond Systems to Present at the June 2020 Virtual Investor Summit – GlobeNewswire

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on C-Bond Systems to Present at the June 2020 Virtual Investor Summit – GlobeNewswire

May 26, 2020 08:31 ET | Source: C-Bond Systems

HOUSTON, May 26, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc.,(OTC: CBNT), a nanotechnology solutions company, today announced that management will present at the June 2020 Virtual Investor Summit on June 9-12, 2020.

Scott R. Silverman, Chief Executive Officer of C-Bond Systems, will host virtual one-on-one investor meetings throughout the conference and is scheduled to present as follows:

Virtual Investor Summit Date: Tuesday, June 9, 2020 Time: 9:45 a.m. Eastern time (6:45 a.m. Pacific time) Webcast: https://www.webcaster4.com/Webcast/Page/2038/35029

Conference participation is by invitation only and registration is mandatory. For more information, or to schedule a virtual one-on-one meeting, please contact your conference representative.

About C-Bond C-Bond Systems, Inc. (OTC: CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The Companys Transportation Solutions Group sells C-Bond NanoShield, a liquid solution applied directly to automotive windshields, sold through distributors. The Companys Safety Solutions Group sells ballistic-resistant glass solutions and C-Bond FN NANO Coating directly to private enterprises, schools, hospitals and government agencies. For more information, please visit the Companys website http://www.cbondsystems.com as well as its Facebookand Twitter profiles.

Houston, Texas, UNITED STATES

Home

Formats available:

Originally posted here:

C-Bond Systems to Present at the June 2020 Virtual Investor Summit - GlobeNewswire

Read the Rest...

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascula | IJN – Dove Medical Press

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascula | IJN – Dove Medical Press

Rajasekharreddy Pala,1,2 VT Anju,3 Madhu Dyavaiah,3 Siddhardha Busi,4 Surya M Nauli1,2

1Department of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618, USA; 2Department of Medicine, University of California Irvine, Irvine, CA 92868, USA; 3Department of Biochemistry and Molecular Biology, School of Life Sciences, Pondicherry University, Puducherry, India; 4Department of Microbiology, School of Life Sciences, Pondicherry University, Puducherry, India

Correspondence: Rajasekharreddy Pala; Surya M Nauli Tel +714-516-5462 ; +714-516-5480 Fax +714-516-5481 Email rrpala@chapman.edu; nauli@chapman.edu

Abstract: Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are not very useful, which demands promising alternative methods. Nanoscience and nanotechnology open a new window in the area of CVDs with an opportunity to achieve effective treatment, better prognosis, and less adverse effects on non-target tissues. The application of nanoparticles and nanocarriers in the area of cardiology has gathered much attention due to the properties such as passive and active targeting to the cardiac tissues, improved target specificity, and sensitivity. It has reported that more than 50% of CVDs can be treated effectively through the use of nanotechnology. The main goal of this review is to explore the recent advancements in nanoparticle-based cardiovascular drug carriers. This review also summarizes the difficulties associated with the conventional treatment modalities in comparison to the nanomedicine for CVDs.

Keywords: cardiovascular diseases, nanoscience, nanoparticles, nanomedicine, nanocarriers, treatment

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more from the original source:

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascula | IJN - Dove Medical Press

Read the Rest...

Sixth Wave and Natural Ascent Consulting to Deploy the Affinity(TM) Platform for Extract Remediation – Yahoo Finance

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Sixth Wave and Natural Ascent Consulting to Deploy the Affinity(TM) Platform for Extract Remediation – Yahoo Finance

Halifax, Nova Scotia--(Newsfile Corp. - May 26, 2020) - Sixth Wave Innovations Inc. (CSE:SIXW) (OTC Pink: ATURF) (FSE: AHUH) (the "Company" or "Sixth Wave") announces a strategic alignment with Natural Ascent Consulting (NAC) and the signing a hardware loan and production agreement which will allow NAC to field test and contribute to the commercialization process of the Company's Affinity cannabinoid purification system for the remediation of non-compliant hemp and cannabis extracts and standard extraction of cannabinoids from other crude extracts. The contract engages NAC in cannabinoid production using the Affinity System, and establishes a Southern California based production hub for Sixth Wave in one of the worlds largest cannabis markets. NAC will also use their lab capability with Sixth Wave to trial multiple production applications for the Affinity System including continued validation of the Systems capability to remediate failed extracts for heavy metals, pesticides, and possibly the chemicals associated with fire retardants that are found in both hemp and cannabis extracts due to their widespread use to combat forest fires.

As an established consulting firm supporting the cannabis and hemp industries, NAC brings an array of knowledge and resources to the venture. With experience in a wide variety of projects, NAC centers on processing CBD / CBG biomass to the highest quality downstream wholesale product lines at an industrial scale. NAC is currently focused on assimilating advanced technologies, such as THC remediation and cannabinoid conversion/isolation, into a contract farming business model for the hemp industry.

Focused on developing nanotechnology applications, Sixth Wave's Molecular Imprinted Polymers (MIPs) have also been applied in industries including homeland security, mining, and pathogen detection. NAC's expertise in hemp/cannabis extraction and processing has resulted in significant benefit to Sixth Wave by providing the rigorous and resource-intensive process development required with cannabinoid specific MIPs.

"After many months of working together, and thanks to the brilliant work of the Sixth Wave team, we have been able to show that THC remediation, full-spectrum cannabinoid isolation from complex tinctures, and pesticide/heavy metal remediation are all quite possible," Kameron Walker, Co-owner of NAC, proudly explained. "We are working through proof of concept which is always the most difficult and tedious part of the process, and expect to turn our focus to production, scale-up, and eventual automation in the months to come."

Jon Gluckman, Sixth Wave CEO, commented, "NAC's experience in engineering industrial chromatography equipment provides turn-key solutions for us to quickly bridge the gap between small-scale proof of concept and full-scale industrial production."

Under the terms of the Agreements, Sixth Wave has provided a complement of test and pilot scale equipment to the NAC laboratory for experimental use designed to develop standard operating proceedures for the remediation applications using a variety of biomass sourced from California. Once completed, NAC will begin processing extracts using the pilot Affinity System in accordance with Sixth Wave's Total System Performance License Agreement which is still under negotiation. Further, Sixth Wave will replace the pilot system with a fully GMP compliant system to meet NAC's expected processing requirments. The NAC team will continue to support roll out and installation/support under contract to Sixth Wave when the Company begins fulfilling delivery of Affinity Systems to other customers.

The Company further advises that it has engaged Hybrid Financial to promote market awareness and further the Company's reach within the investment community. Hybrid will be engaged for a fee of $15,000.00 per month for an initial term of six months, with an automatic renewal for successive three month terms unless canceled by written notice 30 days prior to the end of the term.

About Natural Ascent Consulting

Natural Ascent Consulting, established in 2019, Co-owned by Kameron Walker & Earl Ross, NAC has expertise in implementing customized solutions to maximize process efficiency for demanding clients in the Hemp processing industry, specializing in installation, training, maintenance, and service support of equipment. Other industry provided services include extraction, distillation, and solvent recovery.

Story continues

For more information about Natural Ascent Consulting, visit its web site at: http://www.naturalascentconsulting.com

About Sixth Wave

Sixth Wave is a development stage nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized molecularly imprinted polymers. The Company is in the process of commercializing its AffinityTM cannabinoid purification system, as well as, IXOS, a line of extraction polymers for the gold mining industry.

The nanotechnology architectures, which are the focus of the Company's work, are amenable to other relevant detection and separation problems, including the detection of biogenic amines, viruses, and other pathogens, for which the Company has products at various stages of development.

For more information about Sixth Wave, please visit our web site at: http://www.sixthwave.com

ON BEHALF OF THE BOARD OF DIRECTORS

"Jon Gluckman" Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company: Phone: (801) 582-0559 E-mail: info@sixthwave.com

Cautionary Notes

This press release includes certain statements that may be deemed "forward-looking statements," including statements regarding the AffinityTMSystem scale-up, THC remediation performance, he expected terms of the Total System Performance License and commencement of full-scale production. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, including the risks that AffinityTMSystem performance may not be maintained at production level, that anticipated cost savings and performance levels relative to competing technologies may not be realized, that other technologies with better performance or costs may be developed by competitors, that the regulatory regime related to cannabis and hemp, which has evolved rapidly, may change in a manner adverse to the Company's business, the expected terms of the Total System Performance License and other risks detailed in the Company's filing statement available at http://www.sedar.com, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56554

View post:

Sixth Wave and Natural Ascent Consulting to Deploy the Affinity(TM) Platform for Extract Remediation - Yahoo Finance

Read the Rest...

Ted Sargent receives the Killam Prize in Engineering – U of T Engineering News – U of T Engineering News

§ May 26th, 2020 § Filed under Nanotechnology Comments Off on Ted Sargent receives the Killam Prize in Engineering – U of T Engineering News – U of T Engineering News

University Professor Ted Sargent (ECE) has received this years Killam Prize for Engineering.

This honour means a lot to me, especially when I consider all of the inspiring researchers who have held it in years past, says Sargent. What this award celebrates is a trulyglobal collaborationwithtalented researchersdedicated to building a cleaner, more sustainable world. I see it as a celebration of the remarkably talented students and fellows whom Ive had the privilege of working with in the past two decades as a faculty member in Engineering at U of T.

Awarded by the Canada Council for the Arts, the Killam Prizes celebrate working scientists, writers, doctors and researchers who have dedicated their careers to solving challenges in our daily lives. Also among this years recipients is Professor Barbara Sherwood Lollar (Earth Sciences).

The Killam Prizes are awarded at the same time as the Killam Research Fellowships, which support outstanding scholars as they carry out their groundbreaking projects in a wide range of fields. Professor Milica Radisic (IBBME, ChemE) and Professor Joseph Heath (Philosophy) are among this years recipients.

Read more about Milica Radisics Killam Research Fellowship

Sargent holds the Canada Research Chair in Nanotechnology, and leads a large research lab dedicated to advanced materials such as quantum dots, perovskite crystals and multi-metal catalysts. Applications include light sensing, solar energy harvesting, and carbon capture and storage.

The Sargent group has set a number of world records in the use of colloidal quantum dots (CQDs) to harvest solar energy. They also designed highly efficient CQD light sensors, a technology that was spun off into the startup InVisage Technologies.

Another line of materials research relates to perovskites, which like CQDs can convert sunlight into electricity. Both CQDs and perovskites can be mixed with liquid to create a solar ink that could be used with established technology such as inkjet printers. This manufacturing approach, known as solution processing, could significantly lower the cost of solar cells.

Last month, Sargent and his collaborators reported a new type of tandem solar cell, in which they combined perovskites with traditional silicon solar cells, enabling them to overcome key limitations of the existing technology.

The Sargent lab has also extensively researched the use of electrolyzers devices in which electricity powers a chemical reaction to convert CO2 into common industrial chemicals. This strategy improves the economics of carbon capture and storage by raising the value of captured CO2, while at the same time reducing the need for fossil fuels in the petrochemical industry. As an added bonus, it also provides an outlet for excess electricity from renewable but intermittent sources such as solar or wind power.

Several researchers from the Sargent group have formed a spinoff company, CERT Technologies Inc., to commercialize this research. Last month, CERT was among the winners of the Breakthrough Energy Solutions Canada competition. It is also one of five finalists in theNRG COSIA Carbon XPRIZE, a $20 million competition to design technologies to upgrade CO2 into valuable products.

Read more about recent research from Professor Ted Sargents lab group

Sargent serves as Vice-President, International for the University of Toronto. In this role, he is responsible for strengthening and expanding U of Ts global networks. This includes forming research partnerships with peer institutions and leading companies worldwide as well as expanding opportunities for students to participate in study abroad programs, work-integrated learning placements and other global experiences.

Sargents research has received more than 37,000 citations, with more than 100 of his papers cited more than 100 times. He is a Fellow of the Royal Society of Canada, the American Association for the Advancement of Science, and the Canadian Academy of Engineering. In addition to InVisage and CERT, he has co-founded two more startup companies: QD Solar and Xagenic. His book The Dance of Molecules: How Nanotechnology is Changing Our Lives (Penguin) was published in Canada and the United States in 2005.

Congratulations to Professor Sargent on this well-deserved honour, said Chris Yip, Dean of the Faculty of Applied Science & Engineering. His research impact is truly inspiring, as are his dedication to strengthening our institutions global connections and enriching our entrepreneurship ecosystem. He embodies the spirit of excellence that characterizes our Faculty.

Visit link:

Ted Sargent receives the Killam Prize in Engineering - U of T Engineering News - U of T Engineering News

Read the Rest...

The Pros And Cons Of Genetically Engineering Humans

§ May 26th, 2020 § Filed under Genetically Modified Humans Comments Off on The Pros And Cons Of Genetically Engineering Humans

Today there is a lot of fear and anxiety around the prospect of genetically modify humans beings. Yet it is increasingly looking like this will become more commonplace in the coming decades.

Over the past year, Ive had the opportunity to speak with members of the scientific and business communities working on genetic engineering. Ive discussed with them how this technology could evolve and what some of the potential benefits and risks are to society. In this post, Ill share what Ive learned, in case others find it interesting.

Why should we care about genetic engineering?

It could help eliminate hundreds of diseases. It could eliminate many forms of pain and anxiety. It could increase intelligence and longevity. It could change the scale of human happiness and productivity by many orders of magnitude. There are only a handful of areas of research in the world with this much potential.

Zooming out, genetic engineering could be viewed as a historical event on par with the cambrian explosion in how it changed the pace of evolution. When most people think of evolution theyre thinking about biological evolution through natural selection, but this is just one form. Over time, it will likely be superseded by other forms of evolution that act much more quickly. What are some of these? The candidates in my mind are (1) artificial intelligence, or synthetic life, breeding and mutating at a rapid rate (2) biological life, with genetic engineering being used to take a more directive approach, and (3) some merged hybrid of the two. Instead of waiting hundreds of thousands of years for beneficial mutations to show up (as with natural selection), we could start to see beneficial changes every year.

This all sounds pretty far fetched, I dont think any of it will happen soon in the near future.

Its important to disentangle whether we think something will happen from whether we think it should happen. Many people are uncomfortable with the idea of it happening, and this influences their prediction of how likely it is to happen.

Consider where we are today:

So genetic engineering is already happening on humans today, and I dont see any reason why it would stop.

With the creation of CRISPR and similar techniques, weve seen an explosion in research around making actual edits to DNA. I recommend reading Jennifer Doudna and Samuel Sternbergs book, A Crack In Creation, for a great overview of this topic.

A lot of research is happening, but actually editing human DNA wont be allowed. You dont actually think people should be having designer babies do you?

If it has the potential to eradicate many diseases and minimize human suffering, I think we should continue to research it, with the caution and prudence it deserves.

Some will say that every child has the right to remain genetically unmodified, and others will say that every child has the right to be born free of preventable diseases. We make many decisions on behalf of children to try and help them have a better life, and I dont see why this would be any exception.

Many new medical treatments have similar ethical issues as they are being developed. Typically, new drugs are tested on mice, then terminally ill patients, then slowly wider sets of people. They go through FDA trials for safety and efficacy. There is a well established path to test new therapies. Genetic engineering may have more potential (both for good and for harm) than most new medical treatments, but this doesnt mean that a similar process cant be followed.

The American National Academy of Sciences and National Academy of Medicine also gave qualified support to human genome editing in 2017 once answers have been found to safety and efficiency problemsbut only for serious conditions under stringent oversight.

As for designer babies, people use this term to mean choosing traits like height or eye color that are not related to health. I do think some parents will want to choose attributes like these, but this isnt where most of the potential benefits will come from. Ill discuss this more a bit lower down.

Finally, it wont just be babies. Adults will be genetically modified at some point as well.

I dont know. It just seems wrong to play god and move into this territory.

Think about surgery. Three hundred years ago, it must have seemed quite strange to play god and cut open a human body. Surgery was also an incredibly risky and crude process (someones arm or leg might be amputated on a battlefield in an attempt to save their life, for instance). Over time, surgery became much safer, and we started to use it in less life threatening situations. Today, people undergo purely elective or cosmetic surgery.

The same thing will likely be true with genetic engineering. It may start off being used only in dire situations where people have no other options, but eventually it could become safe enough where people genetically modify themselves for purely cosmetic reasons (for example, to change their hair color). In my view, there is nothing inherently wrong with people wanting to change, improve, or heal their own bodies, even if some uses are more urgent than others. And everyone should make this choice for themselves (I wouldnt presume to make the choice for them).

We wont know the long term effects on people for many decades. I certainly wouldnt want to be one of the first to get it done!

There is a misconception that the first edits made in humans will be totally unpredictable. There are some genes that one in ten people on earth have, that makes them healthier in some way. It will be safer than many people think to introduce this gene into someone who doesnt have it, since it can be widely studied in the existing population. Most new drugs are introduced into the market with just hundreds or thousands of people who have taken it during trial periods, and this is a sufficient bar to demonstrate safety. So a gene that a billion people in the world already have could potentially be far safer than any new drug that has ever come to market.

In addition, new therapies are often tested on terminally ill people who have no other options, so healthy people likely wouldnt be the initial market.

This doesnt mean that there cant be other risks in the procedure, but the idea that an edit to a human genome would have entirely unpredictable results is false.

Many conditions are not controlled by one or two genes. So it wont be as simple as you say to eradicate disease.

This is true. Diseases exist on a spectrum from having a single gene culprit to having many thousands of risk variants which increase or decrease susceptibility to environmental factors. A growing body of research is advancing from uncovering these monogenic (single gene) causes of diseases to uncovering the causes of more complex (polygenic) diseases. Results are improving quickly as a consequence of larger datasets, cheaper sequencing, and use of machine learning.

Even in a world where only simple gene edits were possible, a lot of human suffering could be eliminated. For instance, Verve is developing gene therapies to make heart disease, one of the leading causes of death in the world, less prevalent with relatively small edits. But other conditions, like depression or diabetes, dont seem to be caused by a single gene, or even a handful of genes.

Luckily, machine learning (and techniques like deep learning) are well suited to solving complex, multi-variate, problems like polygenic risk scoring, and machine learning is improving at an incredible rate right now. Companies like GenomicPrediction have started offering polygenic risk scores to expecting parents. In addition, the datasets of sequenced genomes keep getting larger (some have over a million sequenced genomes at this point) which will improve the accuracy of the machine learning models over time.

Many things arent controlled by genetics. You cant make happy/healthy humans just with genetic engineering.

Also true. There are many environmental and lifestyle factors to consider, in addition to genetics. The lifestyle/nurture components are hard challenges in their own right, but thankfully we have some amount of control over them. For instance, we can eat healthier food, go for walks, or exercise. But in contrast, we have very little control of our genetics today.

Most people take it as a given that they can never change their genes, which is actually quite sad if you think about it. It feels terrible to be stuck in any situation where youre powerless to change it. Imagine the person who continually struggles with their weight, no matter how much they focus on exercise and diet, comparing themselves to people who seem to eat whatever they want without gaining a pound. Nature can be very cruel to us, and genes can create an uneven playing field in life. Genetic engineering may not be the whole solution, but it would certainly unlock a big piece of it.

Its a slippery slope from disease prevention to enhancement, where do we draw the line?

The likely answer is that there isnt a clear line, and we wont draw one. The overton window will continue to shift as people become more comfortable with genetic engineering.

Genetic engineering will start by being focused on disease prevention, because this is the most socially acceptable form of it at the moment. But, for instance, if you have a gene that creates low bone density (making you predisposed to osteoporosis), and you correct this with genetic engineering, are your stronger bones preventing disease or are they an enhancement (enabling you to play sports and lift heavy things)? The answer is both. There are many blurry lines like this. To me, the goal is just to improve the human condition, so the distinction between preventing bad outcomes and creating good outcomes becomes less relevant.

In addition, it is worth noting that we do things all the time today to enhance the human body (wearing running shoes, putting on sunblock, corrective lens, etc). And we even do things to enhance ourselves genetically today, like choosing who to have children with or couples who do IVF screening. Genetic enhancement may be scary to some people today, but I think this is mainly just because it is new. Over time, it could be considered as normal as getting LASIK surgery to fix your eyesight.

If everyone wants to have a certain trait, wont this create less diversity in the world?

There are some genes, like those which increase your risk of heart disease, which most people will want to eliminate. So in that sense there might be less genetic diversity. But I dont think this will be an overwhelming trend for two reasons. The first is that there is great variety in human preferences (in what is considered beautful, for instance) and the second is that many people have a desire to stand out and be unique. If it becomes cheap and ubiquitous to become some definition of beautiful then it will no longer hold the same cache, and preferences will evolve, just like in fashion. When you can be whomever you want, I think well actually see much greater diversity, not less.

You can see a glimpse of what this might look in video games today, where people can create their own avatar. When people can be whatever character they want, the range of expression is much greater than in real life.

Genetic engineering could also help same-sex couples have genetically related children, which would be a new development. And it could even lead to children which are the product of more than two people. Imagine a child that is the product of ten, or even a hundred, people.

Finally, we may see people change themselves in ways that cant occur naturally today (webbed fingers? scales? night vision like a cat?). If we are truly able to master genetic engineering over the coming century, there will be many beautiful new forms of individual expression that we cant even imagine today. The very idea of what it means to be human will change.

Many great entrepreneurs and artists had ADHD, Autism, depression, schizophrenia and other conditions which people may want to eliminate with genetic engineering. In this world, wouldnt these qualities be eliminated in the name of conformity and risk aversion?

I dont think so. Parents aspire for their children to be all sorts of things in life: artists, scientists, politicians, generals, religious leaders, entrepreneurs, etc. These each might have some genetic traits in common, and others that are very different. If it turned out that the best chance of becoming a successful artist was to start with a certain set of genes that included ADHD, I suspect many parents would still opt for this.

We will probably find ourselves in a world with far more brilliant outliers, if parents can get a genetic head start on raising the next Picasso or Einstein. Other parents will opt for balance. There is no right or wrong answer, just preferences.

Finally, just because we see examples like the above today, doesnt mean this needs to be the case in the future. Brilliant people are often spikey (outliers in a few areas with severe deficiencies in others), but in a world where genetic engineering is mastered there may be people with all the upside (and more), with little or none of the down side, so there is no guarantee the two need to be linked.

Will this lead to modern day eugenics?

Eugenics was about various political or government groups trying to modify the gene pool through use of force.

The ideal outcome here is freedom of choice for every individual. When people can choose how they want to modify and heal themselves (and their children) I think this will be very liberating. There are people in society who might try to abuse this technology (just like any technology), but as long as it is broadly available I think this mitigates a lot of the risk. Its unlikely that one country or political group would have exclusive access to genetic engineering for long (it is widely researched globally, with a lot of information exchange between groups, both formally and informally).

Some day, genetic engineering may even make it possible to create people who are more tolerant and accepting of others around them. Tribalism is a part of our evolution, and it may have a genetic component. Even children exhibit this quality from a young age. How interesting would it be if people were able to change on this dimension genetically? We dont know how to do this yet, but it could be possible in the future.

Wont this create a world of haves and have nots? What if it is only available to rich people? What if it turns out like Gattaca?

Just like many technologies, genetic engineering will almost certainly be available in developed countries first, and it will be expensive. But this is not unique. Cell phones, airplanes, and even basic sanitation are all unevenly distributed around the world. The beauty of technology is that it tends to drive down costs down over time, so it eventually reaches a wider group of people. The cell phone was once a tool only for rich people on Wall St, and it is now available to even the poorest people in the world. There is an open question about whether genetic engineering will follow a cost curve that is more like technology (lower over time following Moores law) or like healthcare (rising over time following Erooms law), but this has more to do with policy decisions around it I think. The main point is that high initial costs are not a good reason to prevent innovation from happening. If we took this approach, we likely wouldnt have any of the improvements we see in the world today.

Its also true that genetic engineering will offer advantages to those who can access it. This could create a less even playing field in some ways, but in other ways, it could actually make it more fair. Today, some people win the genetic lottery at birth while others lose (for instance, being prone to depression, a learning disability, etc). If any child could start on a level playing field genetically, this feels like a more fair world.

Finally, genetic modification can also take place in adult humans. So even if someone doesnt have access to it at birth, they may still be able to benefit from genetic engineering later in life.

Gattaca misses this last point, implying that you will always be left behind if werent born into an elite group. Reality will probably afford more social mobility, with adults benefiting from new genetic engineering treatments as well. It is a very entertaining film none the less, and I suggest anyone who is interested in the subject watch it.

What if people try to enhance traits like intelligence?

Many intelligent people exist in the world today, and, at least the ethical ones dont seem to pose too much of a problem. So lets say we doubled the number of smart people in the world (by whatever definition of smart you prefer) through genetic engineering, while keeping the percentage of ethical ones the same or greater. Or similarly, we could double the smartness of the existing people. Would this be a problem?

Certainly some good things would happen. The pace of improvement in society would likely increase, for instance, with many more smart, capable, people solving the worlds challenges.

The biggest negative change might be that the rest of us feel a little left behind or bewildered by all the new progress and areas of research, if we didnt similarly have our intelligence increased. This boils down to a question of whether you think we should value overall growth in society, or ones relative place in it, more highly. Each person should answer this for themselves (I dont think there is a right answer).

So it could be a mixed outcome, or very good, depending on your perspective. (Side note: this is a great short story about what it might feel like as society begins to advance.)

One final thought experiment: if people want to become smarter, do we have the right to stop them? If it is by getting an education, most people would say no. If it is through genetic engineering, how is this different?

Should parents be able to choose the genes of their child?

In general, I think yes, because parents choose all sorts of things that have a major impact on their children (what they eat, how they are educated, whether they are born at all, etc) as their guardian. This is a well established concept in the law today, with guardians making major decisions for a child until they turn 18 (or an equivalent age in each country). Once children come of age, they will likely take control of their genetic modification, just as they can make a decision to get a tattoo.

It would be a shame if the genes parents chose for their children were fixed indefinitely into the future. As Ive discussed elsewhere, its likely in the future that genes can be modified in living people, not just embryos. So hopefully children arent stuck with their parents genetic preferences for life.

Conclusion

Imagine that youre an expecting parent. How much would you pay to have the peace of mind that your child will arrive healthy? Imagine you were an adult with a life threatening disease. How much would you pay to receive a cure that required a genetic edit? The answer to these questions says a lot about how genetic engineering is likely to be adopted in the future.

Today, it is widely considered to be unconscionable to genetically modify humans. But I believe that within twenty years, we will see this view change dramatically, to a point where it will be considered unconscionable not to genetically modify people in many cases.

Genetic engineering is one of the highest potential areas of research today. I believe we should continue to invest it, and entrepreneurs should work hard to bring new products to market in this space. Yes, it has risks, and we must proceed with caution. But many new technologies have risks even life threatening ones and we eventually are able to use them to greatly benefit the world. We shouldnt let fear hold back progress on promising new areas of research.

See original here:

The Pros And Cons Of Genetically Engineering Humans

Read the Rest...

Is It Ethical to Create Genetically Edited Humans? – The …

§ May 26th, 2020 § Filed under Genetically Modified Humans Comments Off on Is It Ethical to Create Genetically Edited Humans? – The …

What is your initial reaction to this news and why?

In Chinese Scientist Claims to Use Crispr to Make First Genetically Edited Babies, Gina Kolata, Sui-Lee Wee and Pam Belluck write about the darker side of this milestone:

Ever since scientists created the powerful gene editing technique Crispr, they have braced apprehensively for the day when it would be used to create a genetically altered human being. Many nations banned such work, fearing it could be misused to alter everything from eye color to I.Q.

Now, the moment they feared may have come. On Monday, a scientist in China announced that he had created the worlds first genetically edited babies, twin girls who were born this month.

The researcher, He Jiankui, said that he had altered a gene in the embryos, before having them implanted in the mothers womb, with the goal of making the babies resistant to infection with H.I.V. He has not published the research in any journal and did not share any evidence or data that definitively proved he had done it.

But his previous work is known to many experts in the field, who said many with alarm that it was entirely possible he had.

Its scary, said Dr. Alexander Marson, a gene editing expert at the University of California in San Francisco.

While the United States and many other countries have made it illegal to deliberately alter the genes of human embryos, it is not against the law to do so in China, but the practice is opposed by many researchers there. A group of 122 Chinese scientists issued a statement calling Dr. Hes actions crazy and his claims a huge blow to the global reputation and development of Chinese science.

If human embryos can be routinely edited, many scientists, ethicists and policymakers fear a slippery slope to a future in which babies are genetically engineered for traits like athletic or intellectual prowess that have nothing to do with preventing devastating medical conditions.

While those possibilities might seem far in the future, a different concern is urgent and immediate: safety. The methods used for gene editing can inadvertently alter other genes in unpredictable ways. Dr. He said that did not happen in this case, but it is a worry that looms over the field.

Students, read the entire article, then tell us:

After reading this article, has your initial reaction to this news changed at all? What do you think of Dr. Hes experiment?

Some argue that gene editing is a welcome advance that could eliminate disease. Others see it as a slippery slope that might lead to so-called designer babies who are engineered to be stronger, smarter and more attractive than everyone else. Where do you stand in this debate? Is it ethical to create genetically edited humans? Why or why not?

What legal limits, if any, should be placed on the practice of human gene editing? Should it be banned in any form? Should it be allowed for some reasons and not others? Or should doctors be permitted to freely research and experiment with the genetic engineering of human beings? Why do you think the way you do?

In the 1970s, when the first baby was conceived via in vitro fertilization, millions of people went into a moral panic about doctors playing God and interfering with a natural process. Today, I.V.F. has become a broadly accepted and commonplace practice that has helped millions of people have babies. In your opinion, is the paranoia surrounding genetic editing overblown, as the fear around I.V.F. once was? Or is the alarm about this latest advance legitimate? Can you think of any other instances where panic about some technological advancement was either overdone or turned out to be well-founded? How does it compare to genetic editing?

Go here to see the original:

Is It Ethical to Create Genetically Edited Humans? - The ...

Read the Rest...

« Older Entries Newer Entries »



Page 10«..9101112..2030..»